Cargando…

G-Quadruplex-Based Drug Delivery Systems for Cancer Therapy

G-quadruplexes (G4s) are a class of nucleic acids (DNA and RNA) with single-stranded G-rich sequences. Owing to the selectivity of some G4s, they are emerging as targeting agents to overtake side effects of several potential anticancer drugs, and delivery systems of small molecules to malignant cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopes-Nunes, Jéssica, Oliveira, Paula A., Cruz, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308530/
https://www.ncbi.nlm.nih.gov/pubmed/34358097
http://dx.doi.org/10.3390/ph14070671
_version_ 1783728302751481856
author Lopes-Nunes, Jéssica
Oliveira, Paula A.
Cruz, Carla
author_facet Lopes-Nunes, Jéssica
Oliveira, Paula A.
Cruz, Carla
author_sort Lopes-Nunes, Jéssica
collection PubMed
description G-quadruplexes (G4s) are a class of nucleic acids (DNA and RNA) with single-stranded G-rich sequences. Owing to the selectivity of some G4s, they are emerging as targeting agents to overtake side effects of several potential anticancer drugs, and delivery systems of small molecules to malignant cells, through their high affinity or complementarity to specific targets. Moreover, different systems are being used to improve their potential, such as gold nano-particles or liposomes. Thus, the present review provides relevant data about the different studies with G4s as drug delivery systems and the challenges that must be overcome in the future research.
format Online
Article
Text
id pubmed-8308530
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83085302021-07-25 G-Quadruplex-Based Drug Delivery Systems for Cancer Therapy Lopes-Nunes, Jéssica Oliveira, Paula A. Cruz, Carla Pharmaceuticals (Basel) Review G-quadruplexes (G4s) are a class of nucleic acids (DNA and RNA) with single-stranded G-rich sequences. Owing to the selectivity of some G4s, they are emerging as targeting agents to overtake side effects of several potential anticancer drugs, and delivery systems of small molecules to malignant cells, through their high affinity or complementarity to specific targets. Moreover, different systems are being used to improve their potential, such as gold nano-particles or liposomes. Thus, the present review provides relevant data about the different studies with G4s as drug delivery systems and the challenges that must be overcome in the future research. MDPI 2021-07-13 /pmc/articles/PMC8308530/ /pubmed/34358097 http://dx.doi.org/10.3390/ph14070671 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Lopes-Nunes, Jéssica
Oliveira, Paula A.
Cruz, Carla
G-Quadruplex-Based Drug Delivery Systems for Cancer Therapy
title G-Quadruplex-Based Drug Delivery Systems for Cancer Therapy
title_full G-Quadruplex-Based Drug Delivery Systems for Cancer Therapy
title_fullStr G-Quadruplex-Based Drug Delivery Systems for Cancer Therapy
title_full_unstemmed G-Quadruplex-Based Drug Delivery Systems for Cancer Therapy
title_short G-Quadruplex-Based Drug Delivery Systems for Cancer Therapy
title_sort g-quadruplex-based drug delivery systems for cancer therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308530/
https://www.ncbi.nlm.nih.gov/pubmed/34358097
http://dx.doi.org/10.3390/ph14070671
work_keys_str_mv AT lopesnunesjessica gquadruplexbaseddrugdeliverysystemsforcancertherapy
AT oliveirapaulaa gquadruplexbaseddrugdeliverysystemsforcancertherapy
AT cruzcarla gquadruplexbaseddrugdeliverysystemsforcancertherapy